Pesquisas alternativas:
after armed » after armeo (Expandir a Pesquisa), after arm (Expandir a Pesquisa), after timed (Expandir a Pesquisa)
after ahmed » amer ahmed (Expandir a Pesquisa), aftab ahmed (Expandir a Pesquisa), nazeer ahmed (Expandir a Pesquisa)
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa)
after armed » after armeo (Expandir a Pesquisa), after arm (Expandir a Pesquisa), after timed (Expandir a Pesquisa)
after ahmed » amer ahmed (Expandir a Pesquisa), aftab ahmed (Expandir a Pesquisa), nazeer ahmed (Expandir a Pesquisa)
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa)
401
Por Ruck, Tobias, Afzali, Ali Maisam, Lukat, Karl-Friedrich, Eveslage, Maria, Gross, Catharina C., Pfeuffer, Steffen, Bittner, Stefan, Klotz, Luisa, Melzer, Nico, Wiendl, Heinz, Meuth, Sven G.
Publicado no BMC Neurol (2016)
“... center, single arm, explorative phase IV study including 15 patients with highly active RRMS designed...”Publicado no BMC Neurol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
402
Por Najjar, Samer S., Rao, Sunil V., Melloni, Chiara, Raman, Subha V., Povsic, Thomas J., Melton, Laura, Barsness, Gregory W., Prather, Kristi, Heitner, John F., Kilaru, Rakhi, Gruberg, Luis, Hasselblad, Vic, Greenbaum, Adam B., Patel, Manesh, Kim, Raymond J., Talan, Mark, Ferrucci, Luigi, Longo, Dan L., Lakatta, Edward G., Harrington, Robert A.
Publicado em 2011
“..., placebo-controlled trial with a dose-escalation safety phase and a single-dose (60,000 units of epoetin...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
403
“...OBJECTIVES: To evaluate the technical success, clinical outcome and safety of percutaneously placed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
404
Por Li, Yi, Zhao, Yannan, Gong, Chengcheng, Xie, Yizhao, Hu, Xichun, Zhang, Jian, Wang, Leiping, Zhang, Sheng, Cao, Jun, Tao, Zhonghua, Wang, Biyun
Publicado no Sci Rep (2019)
“... single-arm, phase II MBC studies. In NCT01149798, seventy-three MBC patients received 125 mg/m(2) nab...”Publicado no Sci Rep (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
405
Por Grunberger, George, Bhargava, Anuj, Ly, Trang, Zisser, Howard, Ilag, Liza L., Malone, James, Fan, Ludi, Zhang, Shuyu, Johnson, Jennal
Publicado no Diabetes Obes Metab (2020)
“...AIM: To compare the safety and efficacy of U500‐R delivered by a novel, specifically designed U500...”Publicado no Diabetes Obes Metab (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
406
Por Gurumurthy, Mahalakshmi, Bryant, Andrew, Shanbhag, Smruta
Publicado no Cochrane Database Syst Rev (2014)
“... many years after initial diagnosis and treatment. Evidence‐based management of granulosa cell tumour...”Publicado no Cochrane Database Syst Rev (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
407
Por Stuart Hartshorn, Michael J. Barrett, Mark D. Lyttle, Sue Anne Yee, Alan T. Irvine, in collaboration with Paediatric Emergency Research in the UK and Ireland (PERUKI)
Publicado em 2019-07-01
“... of evidence supporting its safety and efficacy, there is a paucity of randomised controlled trial data...”Publicado em 2019-07-01
Obter o texto integral
Artigo
408
Por Adeoye, Opeolu, Knight, William A., Khoury, Jane, Schmit, Pamela A., Sucharew, Heidi, Broderick, Joseph P., Pancioli, Arthur M.
Publicado em 2014
“...). CONCLUSION: The safety and direction of effect of eptifibatide plus rt-PA was confirmed. A phase III trial...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
409
Por Krop, I. E., Lin, N. U., Blackwell, K., Guardino, E., Huober, J., Lu, M., Miles, D., Samant, M., Welslau, M., Diéras, V.
Publicado no Ann Oncol (2015)
“...BACKGROUND: We characterized the incidence of central nervous system (CNS) metastases after...”Publicado no Ann Oncol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
410
Por Hartshorn, Stuart, Barrett, Michael J., Lyttle, Mark D., Yee, Sue Anne, Irvine, Alan T.
Publicado no Trials (2019)
“... phase III trial assessing the efficacy and safety of methoxyflurane delivered via the Penthrox® inhaler...”Publicado no Trials (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
411
Por Brodowicz, T, Lang, I, Kahan, Z, Greil, R, Beslija, S, Stemmer, S M, Kaufman, B, Petruzelka, L, Eniu, A, Anghel, R, Koynov, K, Vrbanec, D, Pienkowski, T, Melichar, B, Spanik, S, Ahlers, S, Messinger, D, Inbar, M J, Zielinski, C
Publicado no Br J Cancer (2014)
“...) between treatment arms; however, progression-free survival (PFS) and objective response rate were...”Publicado no Br J Cancer (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
412
Por Silk, Ann W., Kaufman, Howard L., Curti, Brendan, Mehnert, Janice M., Margolin, Kim, McDermott, David, Clark, Joseph, Newman, Jenna, Bommareddy, Praveen K., Denzin, Lisa, Najmi, Saltanat, Haider, Azra, Shih, Weichung, Kane, Michael P., Zloza, Andrew
Publicado no Front Oncol (2020)
“... survival was not reached after a minimum 24 months of follow-up time. One-year and 2-year survival rates...”Publicado no Front Oncol (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
413
Por Gale, Jeremy D., Gilbert, Steven, Blumenthal, Samuel, Elliott, Tom, Pergola, Pablo E., Goteti, Kosalaram, Scheele, Wim, Perros-Huguet, Christelle
Publicado no Kidney Int Rep (2018)
“... of albuminuria after 12 weeks of treatment in subjects with type 2 diabetes who received standard of care (SOC...”Publicado no Kidney Int Rep (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
414
Por Fried, Michael W., Buti, Maria, Dore, Gregory J., Flisiak, Robert, Ferenci, Peter, Jacobson, Ira, Marcellin, Patrick, Manns, Michael, Nikitin, Igor, Poordad, Fred, Sherman, Morris, Zeuzem, Stefan, Scott, Jane, Gilles, Leen, Lenz, Oliver, Peeters, Monika, Sekar, Vanitha, De Smedt, Goedele, Beumont-Mauviel, Maria
Publicado em 2013
“...The phase IIb, double-blind, placebo-controlled PILLAR trial investigated the efficacy and safety...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
415
Por Rojas, Arturo, Sposetti, Georgina, Gross, Jorge L., Barbieri, Douglas Eugenio, Duan, Ran, Linetzky, Bruno, De Lana, Janaina Martins, Stempa, Oded, Rodriguez, Angel
Publicado no Diabetol Metab Syndr (2016)
“...BACKGROUND: This post hoc analysis examined the efficacy and safety of twice-daily insulin lispro...”Publicado no Diabetol Metab Syndr (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
416
Por Jullien, Sophie, Ryan, Hannah, Modi, Manish, Bhatia, Rohit
Publicado no Cochrane Database Syst Rev (2016)
“... the intensive phase. Investigators achieved follow‐up beyond 18 months after completing treatment in three out...”Publicado no Cochrane Database Syst Rev (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
417
Por Mascarenhas, John, Hoffman, Ronald, Talpaz, Moshe, Gerds, Aaron T., Stein, Brady, Gupta, Vikas, Szoke, Anita, Drummond, Mark, Pristupa, Alexander, Granston, Tanya, Daly, Robert, Al-Fayoumi, Suliman, Callahan, Jennifer A., Singer, Jack W., Gotlib, Jason, Jamieson, Catriona, Harrison, Claire, Mesa, Ruben, Verstovsek, Srdan
Publicado no JAMA Oncol (2018)
“...)/Janus kinase 2 (JAK2) inhibitor ruxolitinib. OBJECTIVE: To compare the efficacy and safety of JAK2...”Publicado no JAMA Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
418
Por Odhiambo, Collins, Zeh, Clement, Ondoa, Pascale, Omolo, Paul, Akoth, Benta, Lwamba, Humphrey, Lando, Richard, Williamson, John, Otieno, Juliana, Masaba, Rose, Weidle, Paul, Thomas, Timothy
Publicado no PLoS One (2015)
“... children in the Kisumu Breastfeeding Study (KiBS). KiBS was a longitudinal phase IIB, open-label, one-arm...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
419
Por Wong, F, Khan, M, Agarwal, K, Furusyo, N, Hwang, J, Flaherty, J, Kim, K
Publicado no J Can Assoc Gastroenterol (2018)
“...BACKGROUND: Tenofovir Disoproxil Fumarate (TDF) treatment results in high rates of viral...”Publicado no J Can Assoc Gastroenterol (2018)
Obter o texto integral
Obter o texto integral
Artigo
420
Por Wedemeyer, Heiner, Forns, Xavier, Hézode, Christophe, Lee, Samuel S., Scalori, Astrid, Voulgari, Athina, Le Pogam, Sophie, Nájera, Isabel, Thommes, James A.
Publicado no PLoS One (2016)
“... control arms in both studies were stopped because of high rates of virological failure. Numerically lower...”Publicado no PLoS One (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo